PSI Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$465 823
2024
Q4
$465 Hold
100
﹤0.01% 815
2024
Q3
$694 Hold
100
﹤0.01% 801
2024
Q2
$780 Hold
100
﹤0.01% 772
2024
Q1
$710 Hold
100
﹤0.01% 720
2023
Q4
$670 Hold
100
﹤0.01% 786
2023
Q3
$563 Hold
100
﹤0.01% 770
2023
Q2
$552 Hold
100
﹤0.01% 762
2023
Q1
$625 Hold
100
﹤0.01% 706
2022
Q4
$466 Hold
100
﹤0.01% 708
2022
Q3
$0 Hold
100
﹤0.01% 788
2022
Q2
$1K Hold
100
﹤0.01% 719
2022
Q1
$2K Hold
100
﹤0.01% 621
2021
Q4
$3K Hold
100
﹤0.01% 631
2021
Q3
$4K Buy
+100
New +$3.63K ﹤0.01% 602

Other funds holding GDRX

PSI Advisors's GDRX Position: Q1 2025 in Review

PSI Advisors sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 100 shares — an estimated $465 sold.

PSI Advisors first reported a position in GDRX in Q3 2021 and held it in 14 quarters. The position peaked at $4K in Q3 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • PSI Advisors reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • PSI Advisors sold 100 GoodRx Holdings shares in Q1 2025, an estimated $465.
  • PSI Advisors first reported a position in GoodRx Holdings in Q3 2021 and held it in 14 quarters.
  • PSI Advisors's GoodRx Holdings position peaked at $4K in Q3 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on PSI Advisors's 13F filing for Q1 2025, filed 21 Apr 2025.